Cross-talk between the CK2 and AKT signaling pathways in cancer

M Ruzzene, J Bertacchini, A Toker… - Advances in biological …, 2017 - Elsevier
CK2 and AKT display a high degree of cross-regulation of their respective functions, both
directly, through physical interaction and phosphorylation, and indirectly, through an intense …

Posttranslational regulation of phosphatase and tensin homolog (PTEN) and its functional impact on cancer behaviors

W Xu, Z Yang, SF Zhou, N Lu - Drug design, development and …, 2014 - Taylor & Francis
The incidence of cancer is increasing worldwide, but the biochemical mechanisms for the
occurrence of cancer is not fully understood, and there is no cure for advanced tumors …

[HTML][HTML] Protein kinase CK2, a potential therapeutic target in carcinoma management

H Lian, M Su, Y Zhu, Y Zhou… - Asian Pacific journal of …, 2019 - ncbi.nlm.nih.gov
The Protein kinase CK2 (formerly known as casein kinase 2) is a highly conserved
serine/threonine kinase overexpressed in various human carcinomas and its high …

[HTML][HTML] Preclinical in vitro and in vivo evidence of an antitumor effect of CX-4945, a casein kinase II inhibitor, in cholangiocarcinoma

K Zakharia, K Miyabe, Y Wang, D Wu, CD Moser… - Translational …, 2019 - Elsevier
PURPOSE: We investigated the antitumor effect of the casein kinase II (CK2) inhibitor CX-
4945 on cholangiocarcinoma (CCA). METHODS: We assessed the effect of CX-4945 alone …

Casein kinase II (CK2) as a therapeutic target for hematological malignancies

C Gowda, M Sachdev, S Muthusami… - Current …, 2017 - ingentaconnect.com
Background: Casein kinase II (CK2) is a pro-oncogenic protein, which is emerging as a
promising therapeutic target in cancer. Recent studies have revealed an important role for …

Short-chain L-3-hydroxyacyl-CoA dehydrogenase: A novel vital oncogene or tumor suppressor gene in cancers

H Fang, H Li, H Zhang, S Wang, S Xu… - Frontiers in …, 2022 - frontiersin.org
The reprogramming of cellular metabolism is frequently linked to tumorigenesis. Glucose,
fatty acids, and amino acids are the specific substrates involved in how an organism …

An update on PTEN modulators–a patent review

CS Boosani, P Gunasekar… - Expert opinion on …, 2019 - Taylor & Francis
Introduction: A multitude of cellular and physiological functions have been attributed to the
biological activity of PTEN (Phosphatase and tensin homolog) such as inhibiting …

Transcriptional regulation of JARID1B/KDM5B histone demethylase by ikaros, histone deacetylase 1 (HDAC1), and casein kinase 2 (CK2) in B-cell acute …

H Wang, C Song, Y Ding, X Pan, Z Ge, BH Tan… - Journal of Biological …, 2016 - ASBMB
Impaired function of the Ikaros (IKZF1) protein is associated with the development of high-
risk B-cell precursor acute lymphoblastic leukemia (B-ALL). The mechanisms of Ikaros tumor …

Targeting the phosphatidylinositol 3‐kinase/Akt/mechanistic target of rapamycin signaling pathway in B‐lineage acute lymphoblastic leukemia: An update

C Simioni, AM Martelli, G Zauli, M Vitale… - Journal of Cellular …, 2018 - Wiley Online Library
Despite considerable progress in treatment protocols, B‐lineage acute lymphoblastic
leukemia (B‐ALL) displays a poor prognosis in about 15–20% of pediatric cases and about …

IKAROS and CK2 regulate expression of BCL-XL and chemosensitivity in high-risk B-cell acute lymphoblastic leukemia

C Song, Z Ge, Y Ding, BH Tan, D Desai… - Blood, The Journal …, 2020 - ashpublications.org
High-risk B-cell acute lymphoblastic leukemia (B-ALL) is an aggressive disease, often
characterized by resistance to chemotherapy. A frequent feature of high-risk B-ALL is loss of …